Olga Rios

1.4k total citations · 1 hit paper
27 papers, 892 citations indexed

About

Olga Rios is a scholar working on Hematology, Immunology and Cancer Research. According to data from OpenAlex, Olga Rios has authored 27 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 7 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Olga Rios's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (6 papers) and Platelet Disorders and Treatments (5 papers). Olga Rios is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (6 papers) and Platelet Disorders and Treatments (5 papers). Olga Rios collaborates with scholars based in United States, Brazil and Switzerland. Olga Rios's co-authors include Neal S. Young, Colin O. Wu, Phillip Scheinberg, Xingmin Feng, Danielle M. Townsley, Jennifer Lotter, Barbara Weinstein, Bogdan Dumitriu, Marie J. Desierto and Cynthia E. Dunbar and has published in prestigious journals such as New England Journal of Medicine, Blood and British Journal of Haematology.

In The Last Decade

Olga Rios

26 papers receiving 881 citations

Hit Papers

Eltrombopag Added to Stan... 2017 2026 2020 2023 2017 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Olga Rios 703 252 178 144 127 27 892
Alexey Maschan 477 0.7× 231 0.9× 120 0.7× 236 1.6× 147 1.2× 137 854
Guibin Chen 516 0.7× 526 2.1× 157 0.9× 91 0.6× 173 1.4× 31 887
Gianluigi Castoldi 483 0.7× 330 1.3× 278 1.6× 252 1.8× 237 1.9× 36 957
Masanao Teramura 565 0.8× 333 1.3× 184 1.0× 143 1.0× 74 0.6× 43 872
J. C. W. Marsh 984 1.4× 374 1.5× 319 1.8× 349 2.4× 165 1.3× 26 1.3k
P. Dyson 625 0.9× 245 1.0× 127 0.7× 312 2.2× 83 0.7× 19 850
Seung‐Hwan Shin 570 0.8× 133 0.5× 123 0.7× 205 1.4× 162 1.3× 68 777
RH van Oers 317 0.5× 404 1.6× 149 0.8× 205 1.4× 181 1.4× 20 894
Takamasa Katagiri 351 0.5× 268 1.1× 52 0.3× 129 0.9× 89 0.7× 65 641
Silvana Capalbo 289 0.4× 179 0.7× 271 1.5× 166 1.2× 144 1.1× 37 669

Countries citing papers authored by Olga Rios

Since Specialization
Citations

This map shows the geographic impact of Olga Rios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Rios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Rios more than expected).

Fields of papers citing papers by Olga Rios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Rios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Rios. The network helps show where Olga Rios may publish in the future.

Co-authorship network of co-authors of Olga Rios

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Rios. A scholar is included among the top collaborators of Olga Rios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Rios. Olga Rios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutierrez‐Rodrigues, Fernanda, Emma M. Groarke, Lemlem Alemu, et al.. (2024). Longitudinal Contribution of Distinct Hematopoietic Clones during Marrow Recovery in Immune Aplastic Anemia. Blood. 144(Supplement 1). 32–32. 1 indexed citations
2.
Durrani, Jibran, Ruba Shalhoub, Jennifer Lotter, et al.. (2024). Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia. British Journal of Haematology. 205(3). 1170–1179. 3 indexed citations
3.
Shalhoub, Ruba, Jibran Durrani, Olga Rios, et al.. (2023). Alemtuzumab in relapsed immune severe aplastic anemia: Long‐term results of a phase II study. American Journal of Hematology. 98(6). 932–939. 5 indexed citations
4.
Groarke, Emma M., Bhavisha A. Patel, Ruba Shalhoub, et al.. (2022). Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia. Leukemia. 36(9). 2328–2337. 28 indexed citations
5.
Lotter, Jennifer, et al.. (2022). Alemtuzumab and Eltrombopag Combination for Patients with Refractory or Relapsed Severe Aplastic Anemia. Blood. 140(Supplement 1). 10851–10852.
6.
Groarke, Emma M., Bhavisha A. Patel, Fernanda Gutierrez‐Rodrigues, et al.. (2021). Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia. British Journal of Haematology. 192(3). 605–614. 36 indexed citations
7.
Patel, Bhavisha A., Jack Ghannam, Emma M. Groarke, et al.. (2020). Detectable mutations precede late myeloid neoplasia in aplastic anemia. Haematologica. 106(2). 647–650. 12 indexed citations
8.
Giudice, Valentina, Zhijie Wu, Sachiko Kajigaya, et al.. (2018). Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes. Cytokine. 113. 462–465. 33 indexed citations
9.
Giudice, Valentina, Fernanda Gutierrez‐Rodrigues, Sachiko Kajigaya, et al.. (2018). Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes. Haematologica. 103(7). 1150–1159. 37 indexed citations
10.
Giudice, Valentina, Angélique Biancotto, Zhijie Wu, et al.. (2018). Aptamer-based proteomics of serum and plasma in acquired aplastic anemia. Experimental Hematology. 68. 38–50. 15 indexed citations
12.
Townsley, Danielle M., Phillip Scheinberg, Thomas Winkler, et al.. (2017). Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. New England Journal of Medicine. 376(16). 1540–1550. 337 indexed citations breakdown →
13.
Hosokawa, Kohei, Sachiko Kajigaya, Xingmin Feng, et al.. (2016). A plasma microRNA signature as a biomarker for acquired aplastic anemia. Haematologica. 102(1). 69–78. 34 indexed citations
14.
Townsley, Danielle M., James N. Cooper, Thomas Winkler, et al.. (2016). Myeloid Neoplasm Gene Somatic Mutations in Patients with Severe Aplastic Anemia Treated with Eltrombopag and Standard Immunosuppression. Blood. 128(22). 727–727. 1 indexed citations
15.
Dumitriu, Bogdan, Sawa Ito, Xingmin Feng, et al.. (2015). Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. The Lancet Haematology. 3(1). e22–e29. 39 indexed citations
16.
Scheinberg, Phillip, Phillip Scheinberg, Danielle Townsley, et al.. (2014). Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia. American Journal of Hematology. 89(5). 467–469. 22 indexed citations
17.
Scheinberg, Phillip, Phillip Scheinberg, Olga Rios, et al.. (2014). Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia. American Journal of Hematology. 89(6). 571–574. 33 indexed citations
18.
Feng, Xingmin, Phillip Scheinberg, Angélique Biancotto, et al.. (2014). In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia. Haematologica. 99(9). 1433–1440. 24 indexed citations
19.
Feng, Xingmin, Phillip Scheinberg, Leigh Samsel, et al.. (2012). Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 10(8). 1616–1623. 32 indexed citations
20.
Feng, Xingmin, Phillip Scheinberg, Angélique Biancotto, et al.. (2011). Different In Vivo Effects of Horse and Rabbit Antithymocyte Globulin in Patients with Severe Aplastic Anemia. Blood. 118(21). 2399–2399. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026